FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / sunshine-act-compliance-memo.docx
sunshine-act-compliance-memo.docx · 1018-00004

Parties

Penterra Pharmaceuticals Corp
Harkness LLP
Key Personnel Penterra Pharmaceuticals Corp

Dates

May 15, 2023
June 28, 2023
August 14, 2023
July 18, 2023
January 1, 2022
December 31, 2023
March 31, 2024
March 31, 2030

Amounts

$80,000,000
$1.87
$62,400,000
$52,000
$13,000
$2,850,000
$75,000
$37,500
$5,320,000
$40,000

Obligations

The statute and regulations do not distinguish between payments that are proper and those that may raise compliance concerns; all payments to covered recipients must be reported, regardless of their legitimacy or business justification
Importantly, even where individual transfers fall below the de minimis threshold, they must be tracked because the aggregate cap applies on a per-covered-recipient, per-calendar-year basis
To qualify for delayed publication, the research payment must satisfy three conditions: 1
The payment must be made pursuant to a written agreement or protocol for the conduct of research
The research must constitute a "systematic investigation, including research development, testing, and evaluation, designed to develop or contribute to generalizable knowledge
For clinical trials, the payment must be associated with a research study registered on ClinicalTrials